A0A5P6A9N1 (A0A5P6A9N1_9STAP) Staphylococcus argenteus
Staphylococcal enterotoxin type C3 UniProtKBInterProInteractive Modelling
266 aa; Sequence (Fasta) ;
4 identical sequences: Staphylococcus aureus: P0A0L4, P0A0L3, P0A0L5, Q54A76
Available Structures
20 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of HLA-DR1/TPI(23-37) complexed with staphylococcal enterotoxin C3 variant 3B2 (S… |
Heteromer P01903; P01911; P0A0L5; P60174; | 98.26 | ||||
| Human class II MHC protein HLA-DR1 bound to a designed peptide related to influenza virus hemagglut… |
Heteromer P01903; P01911; P03437; P0A0L3; | 98.26 | ||||
| HLA-DR1 complexed with a 13 residue HIV capsid peptide |
Heteromer P01903; P01911; P0A0L5; P12495; | 98.26 | ||||
| Crystal Structure of the MHC Class II Molecule HLA-DR1 in Complex with the Fluorogenic Peptide, AcP… |
Heteromer A8CDU0; P01903; P01911; P0A0L5; | 98.28 | ||||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the… |
Heteromer P01903; P01911; P0A0L5; | 98.28 | ||||
| Crystal structure of T-cell receptor V beta domain variant complexed with superantigen SEC3 |
Heteromer P04213; P0A0L5; | 100 | ||||
| Crystal structure of HLA-DR1/TPI(23-37, Thr28-->Ile mutant) complexed with staphylococcal enterotox… |
Heteromer P01903; P01911; P0A0L5; P60174; | 98.27 | ||||
| HLA-DR1 complexed with a 16 residue HIV capsid peptide bound in a hairpin conformation |
Heteromer P01903; P01911; P0A0L5; P12495; | 98.28 | ||||
| HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) and the superantigen SEC3-3B2 |
Heteromer P01903; P01911; P0A0L5; P27705; | 98.26 | ||||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the… |
Heteromer P01903; P01911; P0A0L5; | 97.84 | ||||
| Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1(HA peptide 306-318) with the … |
Heteromer P01903; P01911; P0A0L5; | 100.0 | ||||
| T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN |
Heteromer P0A0L5; | 96.23 | ||||
| A complex between a variant of staphylococcal enterotoxin C3 and the variable domain of the murine … |
Heteromer P0A0L5; | 98.71 | ||||
| Crystal structure of T-cell receptor V beta domain variant complexed with superantigen SEC3 mutant |
Heteromer P04213; P0A0L5; | 99.01 | 1×ZN; 3×NA; 5×SO4; | |||
| Crystal structure of T-cell receptor V beta domain variant complexed with superantigen SEC3 mutant |
Heteromer P04213; P0A0L5; | 99.01 | ||||
| Manipulating the coupled folding and binding process drives affinity maturation in a protein-protei… |
Heteromer P0A0L5; | 99.01 | 2×SO4; | |||
| Manipulating the coupled folding and binding process drives affinity maturation in a protein-protei… |
Heteromer P0A0L5; | 99.01 | 2×SO4; | |||
| Manipulating the coupled folding and binding process drives affinity maturation in a protein-protei… | monomer | 100.0 | 1×ZN; | |||
| Manipulating the coupled folding and binding process drives affinity maturation in a protein-protei… | monomer | 100.0 | 1×ZN; | |||
| Manipulating the coupled folding and binding process drives affinity maturation in a protein-protei… | monomer | 100.0 | 1×ZN; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1ste.1.A | monomer | 0.85 | 1×ZN; | 98.33 | ||